Multidrug-resistant enteric pathogens in older children and adults with diarrhea in Bangladesh: epidemiology and risk factors.

Antimicrobial resistance Bangladesh Diarrhea Enteric pathogens Global health Low- and middle-income countries Multidrug resistance Resource-limited

Journal

Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093

Informations de publication

Date de publication:
10 May 2021
Historique:
received: 18 01 2021
accepted: 29 04 2021
entrez: 10 5 2021
pubmed: 11 5 2021
medline: 11 5 2021
Statut: epublish

Résumé

Antimicrobial resistance (AMR) is a global public health threat and is increasingly prevalent among enteric pathogens in low- and middle-income countries (LMICs). However, the burden of multidrug-resistant organisms (MDROs) in older children, adults, and elderly patients with acute diarrhea in LMICs is poorly understood. This study's aim was to characterize the prevalence of MDR enteric pathogens isolated from patients with acute diarrhea in Dhaka, Bangladesh, and assess a wide range of risk factors associated with MDR. This study was a secondary analysis of data collected from children over 5 years, adults, and elderly patients with acute diarrhea at the International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka Hospital between March 2019 and March 2020. Clinical, historical, socio-environmental information, and a stool sample for culture and antimicrobial susceptibility testing were collected from each patient. Univariate statistics and multiple logistic regression were used to assess the prevalence of MDR among enteric pathogens and the association between independent variables and presence of MRDOs among culture-positive patients. A total of 1198 patients had pathogens isolated by stool culture with antimicrobial susceptibility results. Among culture-positive patients, the prevalence of MDR was 54.3%. The prevalence of MDR was highest in Aeromonas spp. (81.5%), followed by Campylobacter spp. (72.1%), Vibrio cholerae (28.1%), Shigella spp. (26.2%), and Salmonella spp. (5.2%). Factors associated with having MDRO in multiple logistic regression included longer transport time to hospital (>90 min), greater stool frequency, prior antibiotic use prior to hospital presentation, and non-flush toilet use. However, pseudo-R2 was low 0.086, indicating that other unmeasured variables need to be considered to build a more robust predictive model of MDR. MDR enteric pathogens were common in this study population with clinical, historical, and socio-environmental risk factors associated with MDROs. These findings may help guide clinical decision-making regarding antibiotic use and selection in patients at greatest risk of complications due to MDROs. Further prospective research is urgently needed to determine what additional factors place patients at greatest risk of MDRO, and the best strategies to mitigate the spread of MDR in enteric pathogens.

Sections du résumé

BACKGROUND BACKGROUND
Antimicrobial resistance (AMR) is a global public health threat and is increasingly prevalent among enteric pathogens in low- and middle-income countries (LMICs). However, the burden of multidrug-resistant organisms (MDROs) in older children, adults, and elderly patients with acute diarrhea in LMICs is poorly understood. This study's aim was to characterize the prevalence of MDR enteric pathogens isolated from patients with acute diarrhea in Dhaka, Bangladesh, and assess a wide range of risk factors associated with MDR.
METHODS METHODS
This study was a secondary analysis of data collected from children over 5 years, adults, and elderly patients with acute diarrhea at the International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka Hospital between March 2019 and March 2020. Clinical, historical, socio-environmental information, and a stool sample for culture and antimicrobial susceptibility testing were collected from each patient. Univariate statistics and multiple logistic regression were used to assess the prevalence of MDR among enteric pathogens and the association between independent variables and presence of MRDOs among culture-positive patients.
RESULTS RESULTS
A total of 1198 patients had pathogens isolated by stool culture with antimicrobial susceptibility results. Among culture-positive patients, the prevalence of MDR was 54.3%. The prevalence of MDR was highest in Aeromonas spp. (81.5%), followed by Campylobacter spp. (72.1%), Vibrio cholerae (28.1%), Shigella spp. (26.2%), and Salmonella spp. (5.2%). Factors associated with having MDRO in multiple logistic regression included longer transport time to hospital (>90 min), greater stool frequency, prior antibiotic use prior to hospital presentation, and non-flush toilet use. However, pseudo-R2 was low 0.086, indicating that other unmeasured variables need to be considered to build a more robust predictive model of MDR.
CONCLUSIONS CONCLUSIONS
MDR enteric pathogens were common in this study population with clinical, historical, and socio-environmental risk factors associated with MDROs. These findings may help guide clinical decision-making regarding antibiotic use and selection in patients at greatest risk of complications due to MDROs. Further prospective research is urgently needed to determine what additional factors place patients at greatest risk of MDRO, and the best strategies to mitigate the spread of MDR in enteric pathogens.

Identifiants

pubmed: 33966631
doi: 10.1186/s41182-021-00327-x
pii: 10.1186/s41182-021-00327-x
pmc: PMC8108363
doi:

Types de publication

Journal Article

Langues

eng

Pagination

34

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK116163
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK116163
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54GM115677
Pays : United States

Références

Lancet Infect Dis. 2018 Nov;18(11):1211-1228
pubmed: 30243583
Front Microbiol. 2018 Aug 22;9:1906
pubmed: 30186251
Health Place. 2007 Jun;13(2):381-99
pubmed: 16697689
Glob Health Sci Pract. 2015 Aug 18;3(3):405-18
pubmed: 26374802
BMC Health Serv Res. 2020 Jul 15;20(1):656
pubmed: 32669092
Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S6-9
pubmed: 14681707
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Antimicrob Resist Infect Control. 2015 Jan 28;4:1
pubmed: 25717374
CMAJ. 2011 Feb 22;183(3):339-44
pubmed: 21173060
PLoS Negl Trop Dis. 2021 Mar 10;15(3):e0009266
pubmed: 33690646
J Pharm Policy Pract. 2020 Jun 3;13:20
pubmed: 32514362
BMC Infect Dis. 2019 Sep 11;19(1):801
pubmed: 31510925
Expert Rev Anti Infect Ther. 2014 May;12(5):621-32
pubmed: 24661314
Antimicrob Resist Infect Control. 2018 Sep 14;7:111
pubmed: 30220999
PLoS Negl Trop Dis. 2017 Oct 2;11(10):e0005974
pubmed: 28968393
J Pediatric Infect Dis Soc. 2016 Dec;5(4):366-374
pubmed: 26407270
ISRN Microbiol. 2012 Sep 24;2012:654819
pubmed: 23762755
Am J Trop Med Hyg. 2020 Aug;103(2):652-658
pubmed: 32458788
J Antimicrob Chemother. 2017 Nov 1;72(11):3181-3186
pubmed: 28961759
Emerg Infect Dis. 2007 Nov;13(11):1640-6
pubmed: 18217545
ISRN Microbiol. 2013 Dec 22;2013:213915
pubmed: 24455398
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Lancet Infect Dis. 2005 Aug;5(8):481-93
pubmed: 16048717
J Health Popul Nutr. 2007 Jun;25(2):158-67
pubmed: 17985817
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
Can J Infect Dis Med Microbiol. 2018 Sep 27;2018:2589826
pubmed: 30363711
Lancet Infect Dis. 2020 Feb;20(2):179-187
pubmed: 31843383
BMC Infect Dis. 2019 Dec 2;19(1):1018
pubmed: 31791267
Pathog Immun. 2017;2(1):89-101
pubmed: 28603782
Am J Epidemiol. 2011 Mar 1;173(5):492-8
pubmed: 21262911
Cochrane Database Syst Rev. 2015 Apr 30;(4):CD009647
pubmed: 25924806
PLoS One. 2012;7(3):e33564
pubmed: 22428070
Public Health. 2019 Mar;168:92-101
pubmed: 30716570
J Clin Microbiol. 2013 Jun;51(6):1740-6
pubmed: 23536399
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Bull World Health Organ. 2011 Feb 1;89(2):102-11
pubmed: 21346921

Auteurs

Stephanie C Garbern (SC)

Department of Emergency Medicine, Alpert Medical School, Brown University, 55 Claverick, 2nd Floor, Providence, RI, 02903, USA. sgarbern@brown.edu.

Tzu-Chun Chu (TC)

Center for Statistical Sciences, Brown University, 121 South Main Street, Providence, RI, 02903, USA.

Monique Gainey (M)

Rhode Island Hospital, 593 Eddy St, Providence, RI, 02903, USA.

Samika S Kanekar (SS)

Brown University, 69 Brown St, Providence, RI, 02906, USA.

Sabiha Nasrin (S)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Ave, Dhaka, 1212, Bangladesh.

Kexin Qu (K)

Department of Biostatistics, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.

Meagan A Barry (MA)

Department of Emergency Medicine, Alpert Medical School, Brown University, 55 Claverick, 2nd Floor, Providence, RI, 02903, USA.

Eric J Nelson (EJ)

Departments of Pediatrics and Environmental and Global Health, Emerging Pathogens Institute, University of Florida, 2055 Mowry Road, Gainesville, FL, 32610, USA.

Daniel T Leung (DT)

Division of Infectious Diseases, University of Utah School of Medicine, 30 N 1900 E, Room 4B319, Salt Lake City, UT, 84132, USA.

Christopher H Schmid (CH)

Department of Biostatistics, Brown University School of Public Health, 121 South Main Street, Providence, RI, 02903, USA.

Nur H Alam (NH)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Ave, Dhaka, 1212, Bangladesh.

Adam C Levine (AC)

Department of Emergency Medicine, Alpert Medical School, Brown University, 55 Claverick, 2nd Floor, Providence, RI, 02903, USA.

Classifications MeSH